FY 2022 Highlights
Building on the momentum launched by Texas voters 15 years ago and reauthorized by a decisive statewide vote in November 2019, CPRIT and its grantees advanced innovative research and prevention efforts throughout the state. The year 2022 saw numerous milestones and significant accomplishments for CPRIT and our grantees and grantee institutions, but as always, the beginning and end of our work at CPRIT rests in our grant awards.
As of the end of Fiscal Year 2022, CPRIT had awarded more than $2 billion in academic research grants to almost three dozen research institutions and organizations across Texas. As a result of CPRIT’s investment in active cancer research, Texas institutions have raised over $2.5 billion in additional funding.
This year, the CPRIT prevention program reached a new milestone, surpassing 8 million prevention services provided to Texans in all 254 counties. CPRIT has awarded 274 grants totaling $327 million to institutions and community-based prevention programs across the state.
Since its inception, a crucial part of the CPRIT mission has been to provide early-stage investments in Texas companies developing new cancer-fighting drugs and therapies. CPRIT awarded a Product Development grant to its 50th company in 2022.
CPRIT strives to generate the greatest possible benefit for Texans when awarding grants. The agency supports academic research, product development, and prevention projects that show great scientific promise, meet critical needs, and advance the state’s life science ecosystem. CPRIT’s investments help grantees build novel facilities, achieve scientific breakthroughs, reach clinical milestones, and detect cancers and cancer precursors earlier.
Over the last 13 years, CPRIT has invested $3.12 billion in Texas’ universities, enterprises, and organizations. CPRIT supports the cancer continuum from discovery to delivery, awarding more than 1,794 grants to academic research, product development, and prevention projects across Texas through August 31, 2022.
CPRIT’s $3.12 billion investment in 1,794 of the best ideas in cancer research, product development, and prevention enhances Texas’ role in the global fight against cancer. A snapshot of some notable research findings reported in fiscal year 2022, as well as other important milestones, awards and prestigious appointments, and prevention outreach, are shown below. Click on "View or Download All" to see all the information reported for the fiscal year.